Skip to Content

Vemurafenib

In the US, Vemurafenib (vemurafenib systemic) is a member of the drug class multikinase inhibitors and is used to treat Melanoma, Metastatic.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE15

CAS registry number (Chemical Abstracts Service)

0918504-65-1

Chemical Formula

C23-H18-Cl-F2-N3-O3-S

Molecular Weight

489

Therapeutic Categories

Cytostatic agent

Tyrosine kinase inhibitor

Chemical Names

N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-carbonyl]-2,4,-difluorophenyl}propane-1-sulfonamide (WHO)

Propane-1-sulfonic acid {3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide

Foreign Names

  • Vemurafenibum (Latin)
  • Vemurafenib (German)
  • Vemuraf√©nib (French)
  • Vemurafenib (Spanish)

Generic Names

  • Vemurafenib (OS: USAN, BAN)
  • PLX 4032 (IS)
  • RG 7204 (IS)
  • RO 5185426 (IS)
  • UNII-207SMY3FQT (IS)

Brand Names

  • Zelboraf
    Dr. F. Hoffmann-Lja - Roche, Russian Federation; Genentech, United States; Haemato Pharm, Austria; Hoffmann-La Roche, Bosnia & Herzegowina; Orifarm, Norway; Productos Roche, Chile; Roche, Australia; Roche, Belgium; Roche, Canada; Roche, Colombia; Roche, Germany; Roche, Denmark; Roche, Spain; Roche, Finland; Roche, France; Roche, Georgia; Roche, Greece; Roche, Hong Kong; Roche, Croatia (Hrvatska); Roche, Hungary; Roche, Ireland; Roche, Israel; Roche, Iceland; Roche, Italy; Roche, Lithuania; Roche, Mexico; Roche, Netherlands; Roche, Norway; Roche, New Zealand; Roche, Poland; Roche, Romania; Roche, Sweden; Roche, Thailand; Roche Products, United Kingdom; Roche Registration, Austria

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide